Tatva Chintan Pharma Chem Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
2900.38 Cr.
|
P/BV
|
5.62
|
Book Value (Rs.)
|
220.60
|
52 Week High/Low (Rs.)
|
1888/1061
|
FV/ML
|
10/1
|
P/E(X)
|
63.76
|
Bookclosure
|
22/09/2023
|
EPS (Rs.)
|
19.45
|
Div Yield (%)
|
0.16
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 420.89 | 431.29 | 296.86 | 257.69 | 202.45 |
Other Operating Revenues | 2.72 | 2.35 | 3.50 | 5.55 | 3.86 |
Total Operating Revenues | 423.61 | 433.65 | 300.36 | 263.24 | 206.31 |
| | | | | |
Other Income | 5.74 | 8.89 | 5.93 | 1.38 | 0.49 |
Total Revenue | 429.36 | 442.54 | 306.29 | 264.62 | 206.80 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 215.82 | 254.49 | 150.91 | 146.16 | 118.29 |
Purchase Of Stock-In Trade | 4.58 | 3.68 | 2.54 | 2.45 | 0.28 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 5.71 | -63.53 | -4.06 | -15.84 | -4.33 |
Employee Benefit Expenses | 38.60 | 30.81 | 24.13 | 20.53 | 16.31 |
Finance Costs | 8.40 | 4.83 | 4.21 | 3.95 | 3.63 |
Depreciation And Amortisation Expenses | 9.56 | 8.18 | 6.73 | 4.79 | 4.02 |
Other Expenses | 98.33 | 99.96 | 61.13 | 54.99 | 41.95 |
Total Expenses | 380.99 | 338.42 | 245.60 | 217.03 | 180.16 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 48.37 | 104.12 | 60.70 | 47.60 | 26.64 |
| | | | | |
Exceptional Items | -3.59 | 0.00 | 0.00 | 0.00 | 0.75 |
Profit/Loss Before Tax | 44.78 | 104.12 | 60.70 | 47.60 | 27.39 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 2.89 | 18.98 | 10.81 | 8.00 | 5.28 |
Deferred Tax | -3.59 | -10.73 | -2.38 | 1.15 | 1.69 |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.66 | -0.13 |
Total Tax Expenses | -0.71 | 8.25 | 8.43 | 9.81 | 6.85 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 45.49 | 95.87 | 52.26 | 37.79 | 20.54 |
| | | | | |
Profit/Loss From Continuing Operations | 45.49 | 95.87 | 52.26 | 37.79 | 20.54 |
| | | | | |
Profit/Loss For The Period | 45.49 | 95.87 | 52.26 | 37.79 | 20.54 |
Consolidated Profit/Loss After MI And Associates | 45.49 | 95.87 | 52.26 | 37.79 | 20.54 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 20.52 | 44.59 | 26.02 | 18.81 | 10.23 |
Diluted EPS (Rs.) | 20.52 | 44.59 | 26.02 | 18.81 | 10.23 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 4.43 | 0.00 | 4.02 | 0.00 | 0.00 |